If you’re an adult with Type 2 diabetes who is taking metformin and might benefit from additional treatment to control your blood sugar, you may be interested in participating in a new global study.
The trial aims to determine whether a combination of two approved diabetes treatments is effective in treating the condition when compared to each of the treatments alone, as well as whether the combination causes any side effects.
Eligible participants are men and women age 18 and above who have Type 2 diabetes and have been taking a stable dose of at least 1,500 milligrams of metformin for at least eight weeks. Volunteers must have a body-mass index of 45 or below and cannot be breast-feeding, pregnant, or planning to become pregnant for the duration of the study.
Enrollees will visit the clinic six times over the course of 27 weeks, receiving study treatment in addition to their standard diabetes treatment. Roughly 100 milliliters of blood will be taken over the course of the study for tests, and participants will also be asked to check their fasting blood sugar at least once daily and document the results in a logbook.
Participants will be reimbursed for expenses including travel or parking.
To find a participating clinic near you, and to learn more about the study, visit the study website.
This blog entry was written by Senior Digital Editor Diane Fennell.